Citation Tools

Download PDFPDF

Original research
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

Download to a citation manager

Cite this article as:
Hong DS, Parikh A, Shapiro GI, et al
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers